NASH, acute Liver Failure and Comlications of Liver Cirrhosis Non-Alcoholic Steatohepatitis (NASH) - of the Pathophysiology of innovative Treatment

被引：0
|
作者：
Tilg, Herbert [1 ,2 ]
机构：
[1] Med Univ Innsbruck, Abt Innere Med, Innsbruck, Austria
[2] Med Univ Innsbruck, Christian Doppler Forsch Lab Entzundungsbiol, Innsbruck, Austria
来源：
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH | 2010年 / 60卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：713 / 714
页数：2
相关论文
共 50 条
  • [41] Effect of phlebotomy on non-alcoholic steatohepatitis (NASH).
    Nitecki, J
    Jackson, FW
    Allen, ML
    Farr, VL
    Jackson, FW
    GASTROENTEROLOGY, 2000, 118 (04) : A1474 - A1474
  • [42] Increased Expression of RUNX1 in Liver Correlates with NASH Activity Score in Patients with Non-Alcoholic Steatohepatitis (NASH)
    Kaur, Savneet
    Rawal, Preety
    Siddiqui, Hamda
    Rohilla, Sumati
    Sharma, Shvetank
    Tripathi, Dinesh M.
    Baweja, Sukriti
    Hassan, Mohsin
    Vlaic, Sebastian
    Guthke, Reinhard
    Thomas, Maria
    Dayoub, Rania
    Bihari, Chaggan
    Sarin, Shiv K.
    Weiss, Thomas S.
    CELLS, 2019, 8 (10)
  • [43] Non-alcoholic Steatohepatitis (NASH) and Hepatocellular Carcinoma
    Antonio Cuadrado
    Aitor Orive
    Covadonga García-Suárez
    Agustín Domínguez
    Jose Carlos Fernández-Escalante
    Javier Crespo
    Fernando Pons-Romero
    Obesity Surgery, 2005, 15 : 442 - 446
  • [44] Progression of disease in non-alcoholic steatohepatitis (NASH)
    Kaplan, KJ
    Katz, DE
    Holtzmuller, KC
    Sjogren, MH
    Goodman, ZD
    LABORATORY INVESTIGATION, 1999, 79 (01) : 164A - 164A
  • [45] Laboratory predictors of non-alcoholic steatohepatitis (NASH)
    Bilici, A
    Unsal, B
    McGee, A
    Bolukoglu, H
    Ankoma-Sey, V
    Edwards, M
    HEPATOLOGY, 1999, 30 (04) : 438A - 438A
  • [46] Design and validation of a histologic scoring system for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Kleiner, DE
    Brunt, EM
    Van Natta, ML
    Behling, C
    Contos, MJ
    Cummings, OW
    Ferrell, LD
    Liu, YC
    Torbenson, MS
    Yeh, M
    McCullough, AJ
    Sanyal, AJ
    HEPATOLOGY, 2003, 38 (04) : 233A - 233A
  • [47] Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD)
    Tasneem, Abbas Ali
    Luck, Nasir Hassan
    Majid, Zain
    TROPICAL DOCTOR, 2018, 48 (02) : 107 - 112
  • [48] Predicting the outcome of liver transplantation in patients with non-alcoholic steatohepatitis cirrhosis: The NASH LT risk-benefit calculator
    Karnam, Ravikiran S. S.
    Punchhi, Gopika
    Mitsakakis, Nicholas
    Chen, Shiyi
    Saracino, Giovanna
    Lilly, Leslie
    Asrani, Sumeet K. K.
    Bhat, Mamatha
    CLINICAL TRANSPLANTATION, 2023, 37 (04)
  • [49] Histological study on the resemblance and difference between non-alcoholic steatohepatitis (NASH) and alcoholic liver diseases (ALD)
    Nakano, M
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2005, 29 (12) : 230S - 235S
  • [50] A National Survey of Physicians Regarding Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH): The Disease and Clinical Trial Awareness Program for NASH
    Younossi, Zobair M.
    Stepanova, Maria
    Saenz, Thomas
    Cooper, Gayle
    Schmidt, Christa
    Petruccelli, Steve
    HEPATOLOGY, 2017, 66 : 1184A - 1184A
12345